The effector-like terminal-Tem population (notably also expressing high levels of KLRG1) conferred the greatest protection against Listeria monocytogenes infection but minimal protection against tumor challenge, indicating that protective capacity is highly dependent on the disease and therapeutic context. This evidence concerns the gene KLRG1 and listeriosis.